Skylark Holdings Co., Ltd. (FRA:SKX)

Intra-Cellular Therapies Statistics

Total Valuation

FRA:SKX has a market cap or net worth of EUR 3.87 billion. The enterprise value is 4.46 billion.

Market Cap	3.87B
Enterprise Value	4.46B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	227.50M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	219.33M

Valuation Ratios

The trailing PE ratio is 42.03.

PE Ratio	42.03
Forward PE	n/a
PS Ratio	1.50
PB Ratio	3.58
P/TBV Ratio	n/a
P/FCF Ratio	12.39
P/OCF Ratio	9.36
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 14.28.

EV / Earnings	48.45
EV / Sales	1.83
EV / EBITDA	10.17
EV / EBIT	28.54
EV / FCF	14.28

Financial Position

The company has a current ratio of 0.39, with a Debt / Equity ratio of 0.67.

Current Ratio	0.39
Quick Ratio	0.31
Debt / Equity	0.67
Debt / EBITDA	1.57
Debt / FCF	2.33
Interest Coverage	9.71

Financial Efficiency

Return on equity (ROE) is 8.79% and return on invested capital (ROIC) is 6.02%.

Return on Equity (ROE)	8.79%
Return on Assets (ROA)	3.70%
Return on Invested Capital (ROIC)	6.02%
Return on Capital Employed (ROCE)	7.39%
Revenue Per Employee	419,145
Profits Per Employee	14,974
Employee Count	6,150
Asset Turnover	0.92
Inventory Turnover	21.27

Taxes

In the past 12 months, FRA:SKX has paid 48.97 million in taxes.

Income Tax	48.97M
Effective Tax Rate	34.72%

Stock Price Statistics

The stock price has increased by +38.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+38.21%
50-Day Moving Average	18.28
200-Day Moving Average	16.57
Relative Strength Index (RSI)	5.81
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:SKX had revenue of EUR 2.58 billion and earned 92.09 million in profits. Earnings per share was 0.40.

Revenue	2.58B
Gross Profit	1.73B
Operating Income	165.23M
Pretax Income	141.06M
Net Income	92.09M
EBITDA	463.61M
EBIT	165.23M
Earnings Per Share (EPS)	0.40

Balance Sheet

The company has 102.88 million in cash and 727.54 million in debt, giving a net cash position of -624.67 million.

Cash & Cash Equivalents	102.88M
Total Debt	727.54M
Net Cash	-624.67M
Net Cash Per Share	n/a
Equity (Book Value)	1.08B
Book Value Per Share	4.75
Working Capital	-439.54M

Cash Flow

In the last 12 months, operating cash flow was 413.73 million and capital expenditures -101.31 million, giving a free cash flow of 312.42 million.

Operating Cash Flow	413.73M
Capital Expenditures	-101.31M
Free Cash Flow	312.42M
FCF Per Share	n/a

Margins

Gross margin is 67.11%, with operating and profit margins of 6.41% and 3.57%.

Gross Margin	67.11%
Operating Margin	6.41%
Pretax Margin	5.47%
Profit Margin	3.57%
EBITDA Margin	17.99%
EBIT Margin	6.41%
FCF Margin	12.12%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.67%.

Dividend Per Share	0.11
Dividend Yield	0.67%
Dividend Growth (YoY)	29.65%
Years of Dividend Growth	1
Payout Ratio	28.21%
Buyback Yield	n/a
Shareholder Yield	0.67%
Earnings Yield	2.38%
FCF Yield	8.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:SKX has an Altman Z-Score of 2.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	5